EHRA Premium Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

Topic: Oral Anticoagulation

Congress Session

About the speaker

Doctor Julia Moser

University Heart Center Hamburg, Hamburg (Germany)
0 follower

5 more presentations in this session

Left atrial thrombus in atrial fibrillation/flutter patients in relation to anticoagulation strategy: LATTEE registry

Speaker: Doctor M. Gawalko (Maastricht, NL)

Thumbnail

Detection of atrial fibrillation in patients with cryptogenic stroke: The Nordic Atrial Fibrillation and Stroke (NOR-FIB) study - topline results

Speaker: Doctor B. Ratajczak-Tretel (Sarpsborg, NO)

Thumbnail

Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study

Speaker: Doctor P. Rasmussen (Copenhagen, DK)

Thumbnail

Adherence to oral anticoagulation in a Belgium atrial fibrillation population measured by a medical event monitoring system

Speaker: Miss L. Knaepen (Hasselt, BE)

Thumbnail

Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring

Speaker: Mr L. Xing (Copenhagen, DK)

Thumbnail

Access the full session

What is new on stroke prevention

Speakers: Doctor J. Moser, Doctor M. Gawalko, Doctor B. Ratajczak-Tretel, Doctor P. Rasmussen, Miss L. Knaepen...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Conduction system pacing in paediatric patients: a single centre experience

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

EHRA Premium Access

EHRA position paper on leadless pacing and extravascular defibrillators.

3 April 2022

This platform is supported by

logo Novo Nordisk